Idecabtagene Vicleucel (Ide-Cel) in Patients (pts) with Triple-Class-Exposed (TCE) Relapsed and Refractory Multiple Myeloma (RRMM): the 5-Year Follow-Up Analysis from KarMMa Larry Anderson,Jesus San-Miguel,Thomas Martin,Sundar Jagannath,Jesus G. Berdeja,Sagar Lonial,Noopur Raje,Yi Lin, David Siegel,Albert Oriol,Philippe Moreau,Ibrahim Yakoub-Agha,Tadao Ishida,Anna Truppel-Hartmann,Maria Chaudhry,Arianna Masciulli, Sharavi Peeramsetti,Fan Wu, Md Shamsuzzaman,Ethan Thompson,Nathan Martin,Timothy Campbell,Nikhil MunshiCLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2024）引用 0|浏览1AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
